Salient Capital Advisors’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-61,858
Closed -$5.39M 152
2017
Q2
$5.39M Sell
61,858
-2,314
-4% -$204K 0.11% 65
2017
Q1
$5.77M Sell
64,172
-6,625
-9% -$587K 0.1% 64
2016
Q4
$5.95M Buy
70,797
+73
+0.1% +$6.22K 0.11% 53
2016
Q3
$6.35M Buy
70,724
+1,637
+2% +$142K 0.13% 58
2016
Q2
$5.85M Sell
69,087
-7,839
-10% -$643K 0.13% 62
2016
Q1
$6.33M Buy
76,926
+3,896
+5% +$314K 0.18% 58
2015
Q4
$5.8M Buy
73,030
+27,355
+60% +$2.09M 0.15% 66
2015
Q3
$3.29M Buy
45,675
+3,699
+9% +$277K 0.08% 84
2015
Q2
$3.28M Buy
41,976
+12,773
+44% +$1.03M 0.06% 95
2015
Q1
$2.39M Sell
29,203
-495
-2% -$42.6K 0.04% 99
2014
Q4
$2.71M Buy
29,698
+2,415
+9% +$212K 0.05% 97
2014
Q3
$2.29M Sell
27,283
-651
-2% -$53.3K 0.04% 110
2014
Q2
$2.19M Sell
27,934
-6,957
-20% -$561K 0.05% 99
2014
Q1
$2.81M Sell
34,891
-2,878
-8% -$227K 0.08% 85
2013
Q4
$3.08M Buy
37,769
+671
+2% +$54.7K 0.1% 78
2013
Q3
$2.8M Buy
37,098
+613
+2% +$48.8K 0.12% 67
2013
Q2
$2.81M Buy
+36,485
New +$2.86M 0.13% 64

Other funds holding PG

Salient Capital Advisors's PG Position: Q3 2017 in Review

Salient Capital Advisors sold out of Procter & Gamble (PG) in Q3 2017, closing a stake of 61,858 shares — an estimated $5.39M sold.

Salient Capital Advisors first reported a position in PG in Q2 2013 and held it in 17 quarters. The position peaked at $6.35M in Q3 2016. 2,077 funds tracked by Wall St. Rank hold PG as of Q3 2017.

  • Salient Capital Advisors reported no remaining Procter & Gamble position as of Q3 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 61,858 Procter & Gamble shares in Q3 2017, an estimated $5.39M.
  • Salient Capital Advisors first reported a position in Procter & Gamble in Q2 2013 and held it in 17 quarters.
  • Salient Capital Advisors's Procter & Gamble position peaked at $6.35M in Q3 2016.
  • 2,077 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.